Health In Tech, Inc.
NASDAQ:HITSoftware - Application
+$0.00 today
- Market cap
- $50.13M
- Beta
- 2.94
- P/E (TTM)
- -75.2
- EPS (TTM)
- -$0.01
Volume 0.04M
Average 0.23M
HIT EBITDA Margin
EBITDA as a percentage of revenue.
Health In Tech, Inc.NASDAQ: HIT
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to -19.0%
EBITDA Margin was -19.0% in Q1 FY2026, down 29.2 pp from a year earlier. On a trailing-twelve-month basis it was 0.3%, down 9.8 pp year over year. Over 3 fiscal years it widened by 4.2 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 2 analysts of -12.4% for the fiscal year ending Dec 2026, down from 7.7% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -19.0%-18.5 pp QoQ
- Last fiscal yearDec 2025
- 7.7%-2.2 pp YoY
- LTMMar 2026
- 0.3%-9.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -29.2 pp | -26.5 pp | +2.7 pp |
| 1 year | -2.2 pp | -20.1 pp | -18.0 pp |
| 3 years | +4.2 pp | — | — |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 7.7%
- Year-over-year change
- -2.2pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.7% | -2.2pp |
| FY2024 | 2024-12-31 | 9.9% | -9.8pp |
| FY2023 | 2023-12-31 | 19.6% | +16.1pp |
| FY2022 | 2022-12-31 | 3.6% | — |
EBITDA Margin vs competitors
How HIT compares with its peers on the latest reported figures
- HIT's LTM Mar 2026 EBITDA Margin of 0.3% is the 3rd highest of the 8 companies compared; the peer median is -23.9%.
- Its year-over-year change of -9.8 pp is the 5th highest of 8, against a peer median of -1.0 pp.
- Over three fiscal years its change of +4.2 pp compares with a peer median of -0.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 143.7% | +634.0 pp | +156.7 pp | |
| LTM Mar 2026 | 8.5% | -1.0 pp | +26.9 pp | |
HITHealth In Tech, Inc. | LTM Mar 2026 | 0.3% | -9.8 pp | +4.2 pp |
| LTM Mar 2026 | -7.1% | -12.2 pp | -0.1 pp | |
TEADTeads Holding Co. | LTM Mar 2026 | -23.9% | -23.2 pp | -27.1 pp |
SVCOSilvaco Group, Inc. Common Stock | LTM Mar 2026 | -39.6% | +59.9 pp | -61.3 pp |
LAWRRobot Consulting Co., Ltd. ADS | FY2025 | -78.7% | +16.5 pp | +16.0 pp |
| FY2025 | -158.6% | -47.6 pp | -200.6 pp | |
| Peer median (excluding HIT) | -23.9% | -1.0 pp | -0.1 pp | |
Competitors are the stored peer set for HIT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 5.77M | 19.15M | 19.49M | 33.33M |
| Cost of Revenue | 334.19K | 2.3M | 4.05M | 12.39M |
| Gross Profit | 5.44M | 16.85M | 15.44M | 20.94M |
| Gross Margin | 94.2% | 88.0% | 79.2% | 62.8% |
| Research & Development | 794.62K | 2M | 2.81M | 1.57M |
| Selling, General & Admin | 4.44M | 11.46M | 11.64M | 17.84M |
| Operating Expenses | 5.23M | 13.46M | 14.45M | 19.41M |
| Depreciation & Amortization | 0 | 339.3K | 541.14K | 900.58K |
| EBITDA | 205.58K | 3.76M | 1.93M | 2.57M |
| EBITDA Margin | 3.6% | 19.6% | 9.9% | 7.7% |
| Operating Income | 205.58K | 3.38M | 989.9K | 1.53M |
| Operating Margin | 3.6% | 17.7% | 5.1% | 4.6% |
| Interest Income | 0 | 40.86K | 122.89K | 409.92K |
| Interest Expense | 4.57K | 2.05K | 495K | 0 |
| Other Income / Expenses | (4.57K) | 38.81K | (100.9K) | 145.73K |
| Income Before Tax | 201.01K | 3.42M | 889K | 1.67M |
| Pre-Tax Margin | 3.5% | 17.9% | 4.6% | 5.0% |
| Income Tax Expense | 121.27K | 945.24K | 218.52K | 395.33K |
| Net Income | 79.74K | 2.48M | 670.48K | 1.28M |
| Net Margin | 1.4% | 12.9% | 3.4% | 3.8% |
| EPS (Basic) | 0.00 | 0.05 | 0.01 | 0.02 |
| EPS (Diluted) | 0.00 | 0.05 | 0.01 | 0.02 |
| Weighted Avg Shares | 54.07M | 54.07M | 67.05M | 55.84M |
| Weighted Avg Shares (Diluted) | 54.07M | 54.07M | 53.66M | 57.74M |
Health In Tech, Inc.
NASDAQ:HIT
Intrinsic Alpha fair value
Locked
Current Price
$0.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.